TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumors.
Saved in:
| Title: | TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumors. |
|---|---|
| Authors: | Gymnopoulos M; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Betancourt O; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Blot V; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Fujita R; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Galvan D; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Lieuw V; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Nguyen S; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Snedden J; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Stewart C; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Villicana J; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Wojciak J; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Wong E; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Pardo R; Spirogen, a member of the AstraZeneca Group, London, UK., Patel N; Spirogen, a member of the AstraZeneca Group, London, UK., D'Hooge F; Spirogen, a member of the AstraZeneca Group, London, UK., Vijayakrishnan B; Spirogen, a member of the AstraZeneca Group, London, UK., Barry C; Spirogen, a member of the AstraZeneca Group, London, UK., Hartley JA; Spirogen, a member of the AstraZeneca Group, London, UK., Howard PW; Spirogen, a member of the AstraZeneca Group, London, UK., Newman R; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA., Coronella J; Tanabe Research Laboratories U.S.A., Inc., San Diego, CA, USA. |
| Source: | Molecular oncology [Mol Oncol] 2020 Jan; Vol. 14 (1), pp. 54-68. Date of Electronic Publication: 2019 Dec 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1878-0261 |
|---|---|
| DOI: | 10.1002/1878-0261.12600 |
